268 related articles for article (PubMed ID: 8974711)
1. [Donor exclusions, discarded blood and transfusion unsuited blood conserves of 2,13 million potential blood donors 1991 to 1994].
Diekamp U; Wehrend W; Marklof E; Kamutzky K
Beitr Infusionsther Transfusionsmed; 1996; 33():81-92. PubMed ID: 8974711
[TBL] [Abstract][Full Text] [Related]
2. [HIV retrospective study of the German Red Cross blood donation service in Germany].
Glück D; Elbert G; Dengler T; Gossrau E; Grässmann W; Grimm M; Holzberger G; Sternberger J; Weise W; Kubanek B
Infusionsther Transfusionsmed; 1994 Dec; 21(6):368-75. PubMed ID: 7873915
[TBL] [Abstract][Full Text] [Related]
3. [A retrospective study of the practice of "look-back" procedures, on the incidence of HIV-1/2-positive blood donors and the risk of transfusion-associated HIV infection in public-community blood banks in Germany].
Zeiler T; Kretschmer V; Sibrowski W
Infusionsther Transfusionsmed; 1994 Dec; 21(6):362-7. PubMed ID: 7873914
[TBL] [Abstract][Full Text] [Related]
4. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers.
Cable R; Musavi F; Notari E; Zou S;
Transfusion; 2008 Jan; 48(1):34-42. PubMed ID: 17894796
[TBL] [Abstract][Full Text] [Related]
5. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
6. [Anti-hepatitis C prevalence and incidence in 2.8 million blood donors in Lower Saxony--residual transfusion-associated HCV risk].
Diekamp U; Kamutzky K; Windel CD
Beitr Infusionsther Transfusionsmed; 1997; 34():5-10. PubMed ID: 9417352
[TBL] [Abstract][Full Text] [Related]
7. Effect of a national disaster on blood supply and safety: the September 11 experience.
Glynn SA; Busch MP; Schreiber GB; Murphy EL; Wright DJ; Tu Y; Kleinman SH;
JAMA; 2003 May; 289(17):2246-53. PubMed ID: 12734136
[TBL] [Abstract][Full Text] [Related]
8. Romanian blood donors screening: is it really necessary and/or mandatory?
Hâţu G; Brumboiu MI; Gorgan IN; Bocşan IS
Rev Med Chir Soc Med Nat Iasi; 2013; 117(3):741-6. PubMed ID: 24502043
[TBL] [Abstract][Full Text] [Related]
9. [Screening for HIV-1 antibodies in recipients of potentially HIV infected preserved blood].
Grunenberg R; Krüger J
Beitr Infusionsther; 1990; 26():12-4. PubMed ID: 1703809
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
McFarland W; Mvere D; Katzenstein D
AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
[TBL] [Abstract][Full Text] [Related]
11. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
[TBL] [Abstract][Full Text] [Related]
12. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
[TBL] [Abstract][Full Text] [Related]
13. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South Africa.
Heyns Adu P; Benjamin RJ; Swanevelder JP; Laycock ME; Pappalardo BL; Crookes RL; Wright DJ; Busch MP
JAMA; 2006 Feb; 295(5):519-26. PubMed ID: 16449617
[TBL] [Abstract][Full Text] [Related]
15. [Transfusion-induced virus infections: how great is the risk?].
Sibrowski W; Penner M; Kühnl P
Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():4-9. PubMed ID: 8374287
[TBL] [Abstract][Full Text] [Related]
16. [Infection epidemiological data among blood donors in Germany 2003-2004. Report of the Robert Koch Institute in accordance with Article 22 of the Transfusion Act].
Offergeld R; Ritter S; Faensen D; Hamouda O
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Nov; 48(11):1273-87. PubMed ID: 16249868
[TBL] [Abstract][Full Text] [Related]
17. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the confidential unit exclusion form: the Canadian Blood Services experience.
O'Brien SF; Fan W; Xi G; Yi QL; Goldman M
Vox Sang; 2010 Feb; 98(2):138-44. PubMed ID: 19754523
[TBL] [Abstract][Full Text] [Related]
19. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors.
Busch MP; Glynn SA; Stramer SL; Strong DM; Caglioti S; Wright DJ; Pappalardo B; Kleinman SH;
Transfusion; 2005 Feb; 45(2):254-64. PubMed ID: 15660836
[TBL] [Abstract][Full Text] [Related]
20. Risk of HIV infection from blood transfusion in Montreal.
Remis RS; Delage G; Palmer RW
CMAJ; 1997 Aug; 157(4):375-82. PubMed ID: 9275944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
